Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery

Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated, comprehensive instrument to quantify QOL is required. We aim to evaluate the validity of the 35 item anterior skull base questionnaire (ASBQ-35) in patie...

Full description

Saved in:
Bibliographic Details
Published in:Neurosurgical review 2022-12, Vol.46 (1), p.7-7, Article 7
Main Authors: Castle-Kirszbaum, Mendel, Wang, Yi Yuen, King, James, Kam, Jeremy, Shi, Margaret D. Y., Goldschlager, Tony
Format: Article
Language:English
Subjects:
Humans
Medicine
Medicine & Public Health
Neurosurgery
Pituitary Neoplasms - surgery
Quality of Life
Reproducibility of Results
Skull Base
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c298t-726cec6408f32dcaf1eb13761082bfa9fd6a36efeeb44e696e5cf188d03e57353
container_end_page 7
container_issue 1
container_start_page 7
container_title Neurosurgical review
container_volume 46
creator Castle-Kirszbaum, Mendel
Wang, Yi Yuen
King, James
Kam, Jeremy
Shi, Margaret D. Y.
Goldschlager, Tony
description Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated, comprehensive instrument to quantify QOL is required. We aim to evaluate the validity of the 35 item anterior skull base questionnaire (ASBQ-35) in patients undergoing pituitary adenoma surgery. A total of 168 patients undergoing endoscopic resection of pituitary adenomas underwent longitudinal QOL assessment using the ASBQ-35 and the 22-item Sinonasal Outcomes Test (SNOT-22) over the first postoperative year. Validity of the ASBQ-35 was assessed by internal consistency, test–retest reliability, responsiveness to clinical change, and concurrent validity with the SNOT-22. Internal consistency of the ASBQ-35 was excellent, with a Cronbach’s alpha > 0.95 across all timepoints. Test–retest reliability between 3 and 6 months (ICC = 0.82, p  
doi_str_mv 10.1007/s10143-022-01921-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2753306780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2753306780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-726cec6408f32dcaf1eb13761082bfa9fd6a36efeeb44e696e5cf188d03e57353</originalsourceid><addsrcrecordid>eNp9kE1PxCAQhonRuOvHH_BgOHqpDtDS9mg2fiWbeFGPEkoHRbuwQnvw34uuGk-ehgzPvJl5CDlicMoA6rPEgJWiAM4LYC1nBdsi89ypCy44bP95z8heSi8ArG6B7ZKZkGXDOYc5eXzQg-v16IKnwdLxGan2I0YXIk2v0zDQTiekbxOmT8ZrF5GKijpP0fchmbB2hq7dOLlRx3eqe_RhpWma4hPG9wOyY_WQ8PC77pP7y4u7xXWxvL26WZwvC8PbZixqLg0aWUJjBe-Ntgw7JmrJoOGd1a3tpRYSLWJXlihbiZWxrGl6EFjVohL75GSTu47ha1e1csngMGiPYUqK15UQIOsGMso3qIkhpYhWraNb5d0VA_XpVW28quxVfXlVLA8df-dP3Qr735EfkRkQGyDlL59PVy9hij7f_F_sByTYhGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753306780</pqid></control><display><type>article</type><title>Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Castle-Kirszbaum, Mendel ; Wang, Yi Yuen ; King, James ; Kam, Jeremy ; Shi, Margaret D. Y. ; Goldschlager, Tony</creator><creatorcontrib>Castle-Kirszbaum, Mendel ; Wang, Yi Yuen ; King, James ; Kam, Jeremy ; Shi, Margaret D. Y. ; Goldschlager, Tony</creatorcontrib><description>Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated, comprehensive instrument to quantify QOL is required. We aim to evaluate the validity of the 35 item anterior skull base questionnaire (ASBQ-35) in patients undergoing pituitary adenoma surgery. A total of 168 patients undergoing endoscopic resection of pituitary adenomas underwent longitudinal QOL assessment using the ASBQ-35 and the 22-item Sinonasal Outcomes Test (SNOT-22) over the first postoperative year. Validity of the ASBQ-35 was assessed by internal consistency, test–retest reliability, responsiveness to clinical change, and concurrent validity with the SNOT-22. Internal consistency of the ASBQ-35 was excellent, with a Cronbach’s alpha &gt; 0.95 across all timepoints. Test–retest reliability between 3 and 6 months (ICC = 0.82, p  &lt; 0.001) and 6 months and 12 months (ICC = 0.78, p  &lt; 0.001) was robust. Concurrent validity with SNOT-22 was strong across all timepoints (absolute Pearson r  ≥ 0.63, p  &lt; 0.001). Mean ASBQ-35 scores were significantly worse at 3 weeks compared to preoperative baseline (mean difference − 0.28, p  &lt; 0.01); however, by 12 months, scores had significantly improved (mean difference + 0.24, p  &lt; 0.01), indicating that the scale is responsive to clinical change. Each of the 6 domains of the ASBQ, and all 35 component questions, contributed to the discriminative of the ASBQ to measure QOL during the first postoperative year. The ASBQ-35 is a valid, comprehensive tool for assessing QOL after endoscopic pituitary adenoma surgery. Each component of the ASBQ-35 contributed to the overall assessment of QOL during the first postoperative year.</description><identifier>ISSN: 1437-2320</identifier><identifier>EISSN: 1437-2320</identifier><identifier>DOI: 10.1007/s10143-022-01921-1</identifier><identifier>PMID: 36482220</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Humans ; Medicine ; Medicine &amp; Public Health ; Neurosurgery ; Pituitary Neoplasms - surgery ; Quality of Life ; Reproducibility of Results ; Skull Base</subject><ispartof>Neurosurgical review, 2022-12, Vol.46 (1), p.7-7, Article 7</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-726cec6408f32dcaf1eb13761082bfa9fd6a36efeeb44e696e5cf188d03e57353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36482220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castle-Kirszbaum, Mendel</creatorcontrib><creatorcontrib>Wang, Yi Yuen</creatorcontrib><creatorcontrib>King, James</creatorcontrib><creatorcontrib>Kam, Jeremy</creatorcontrib><creatorcontrib>Shi, Margaret D. Y.</creatorcontrib><creatorcontrib>Goldschlager, Tony</creatorcontrib><title>Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery</title><title>Neurosurgical review</title><addtitle>Neurosurg Rev</addtitle><addtitle>Neurosurg Rev</addtitle><description>Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated, comprehensive instrument to quantify QOL is required. We aim to evaluate the validity of the 35 item anterior skull base questionnaire (ASBQ-35) in patients undergoing pituitary adenoma surgery. A total of 168 patients undergoing endoscopic resection of pituitary adenomas underwent longitudinal QOL assessment using the ASBQ-35 and the 22-item Sinonasal Outcomes Test (SNOT-22) over the first postoperative year. Validity of the ASBQ-35 was assessed by internal consistency, test–retest reliability, responsiveness to clinical change, and concurrent validity with the SNOT-22. Internal consistency of the ASBQ-35 was excellent, with a Cronbach’s alpha &gt; 0.95 across all timepoints. Test–retest reliability between 3 and 6 months (ICC = 0.82, p  &lt; 0.001) and 6 months and 12 months (ICC = 0.78, p  &lt; 0.001) was robust. Concurrent validity with SNOT-22 was strong across all timepoints (absolute Pearson r  ≥ 0.63, p  &lt; 0.001). Mean ASBQ-35 scores were significantly worse at 3 weeks compared to preoperative baseline (mean difference − 0.28, p  &lt; 0.01); however, by 12 months, scores had significantly improved (mean difference + 0.24, p  &lt; 0.01), indicating that the scale is responsive to clinical change. Each of the 6 domains of the ASBQ, and all 35 component questions, contributed to the discriminative of the ASBQ to measure QOL during the first postoperative year. The ASBQ-35 is a valid, comprehensive tool for assessing QOL after endoscopic pituitary adenoma surgery. Each component of the ASBQ-35 contributed to the overall assessment of QOL during the first postoperative year.</description><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosurgery</subject><subject>Pituitary Neoplasms - surgery</subject><subject>Quality of Life</subject><subject>Reproducibility of Results</subject><subject>Skull Base</subject><issn>1437-2320</issn><issn>1437-2320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PxCAQhonRuOvHH_BgOHqpDtDS9mg2fiWbeFGPEkoHRbuwQnvw34uuGk-ehgzPvJl5CDlicMoA6rPEgJWiAM4LYC1nBdsi89ypCy44bP95z8heSi8ArG6B7ZKZkGXDOYc5eXzQg-v16IKnwdLxGan2I0YXIk2v0zDQTiekbxOmT8ZrF5GKijpP0fchmbB2hq7dOLlRx3eqe_RhpWma4hPG9wOyY_WQ8PC77pP7y4u7xXWxvL26WZwvC8PbZixqLg0aWUJjBe-Ntgw7JmrJoOGd1a3tpRYSLWJXlihbiZWxrGl6EFjVohL75GSTu47ha1e1csngMGiPYUqK15UQIOsGMso3qIkhpYhWraNb5d0VA_XpVW28quxVfXlVLA8df-dP3Qr735EfkRkQGyDlL59PVy9hij7f_F_sByTYhGA</recordid><startdate>20221208</startdate><enddate>20221208</enddate><creator>Castle-Kirszbaum, Mendel</creator><creator>Wang, Yi Yuen</creator><creator>King, James</creator><creator>Kam, Jeremy</creator><creator>Shi, Margaret D. Y.</creator><creator>Goldschlager, Tony</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221208</creationdate><title>Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery</title><author>Castle-Kirszbaum, Mendel ; Wang, Yi Yuen ; King, James ; Kam, Jeremy ; Shi, Margaret D. Y. ; Goldschlager, Tony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-726cec6408f32dcaf1eb13761082bfa9fd6a36efeeb44e696e5cf188d03e57353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosurgery</topic><topic>Pituitary Neoplasms - surgery</topic><topic>Quality of Life</topic><topic>Reproducibility of Results</topic><topic>Skull Base</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castle-Kirszbaum, Mendel</creatorcontrib><creatorcontrib>Wang, Yi Yuen</creatorcontrib><creatorcontrib>King, James</creatorcontrib><creatorcontrib>Kam, Jeremy</creatorcontrib><creatorcontrib>Shi, Margaret D. Y.</creatorcontrib><creatorcontrib>Goldschlager, Tony</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurosurgical review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castle-Kirszbaum, Mendel</au><au>Wang, Yi Yuen</au><au>King, James</au><au>Kam, Jeremy</au><au>Shi, Margaret D. Y.</au><au>Goldschlager, Tony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery</atitle><jtitle>Neurosurgical review</jtitle><stitle>Neurosurg Rev</stitle><addtitle>Neurosurg Rev</addtitle><date>2022-12-08</date><risdate>2022</risdate><volume>46</volume><issue>1</issue><spage>7</spage><epage>7</epage><pages>7-7</pages><artnum>7</artnum><issn>1437-2320</issn><eissn>1437-2320</eissn><abstract>Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated, comprehensive instrument to quantify QOL is required. We aim to evaluate the validity of the 35 item anterior skull base questionnaire (ASBQ-35) in patients undergoing pituitary adenoma surgery. A total of 168 patients undergoing endoscopic resection of pituitary adenomas underwent longitudinal QOL assessment using the ASBQ-35 and the 22-item Sinonasal Outcomes Test (SNOT-22) over the first postoperative year. Validity of the ASBQ-35 was assessed by internal consistency, test–retest reliability, responsiveness to clinical change, and concurrent validity with the SNOT-22. Internal consistency of the ASBQ-35 was excellent, with a Cronbach’s alpha &gt; 0.95 across all timepoints. Test–retest reliability between 3 and 6 months (ICC = 0.82, p  &lt; 0.001) and 6 months and 12 months (ICC = 0.78, p  &lt; 0.001) was robust. Concurrent validity with SNOT-22 was strong across all timepoints (absolute Pearson r  ≥ 0.63, p  &lt; 0.001). Mean ASBQ-35 scores were significantly worse at 3 weeks compared to preoperative baseline (mean difference − 0.28, p  &lt; 0.01); however, by 12 months, scores had significantly improved (mean difference + 0.24, p  &lt; 0.01), indicating that the scale is responsive to clinical change. Each of the 6 domains of the ASBQ, and all 35 component questions, contributed to the discriminative of the ASBQ to measure QOL during the first postoperative year. The ASBQ-35 is a valid, comprehensive tool for assessing QOL after endoscopic pituitary adenoma surgery. Each component of the ASBQ-35 contributed to the overall assessment of QOL during the first postoperative year.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>36482220</pmid><doi>10.1007/s10143-022-01921-1</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1437-2320
ispartof Neurosurgical review, 2022-12, Vol.46 (1), p.7-7, Article 7
issn 1437-2320
1437-2320
language eng
recordid cdi_proquest_miscellaneous_2753306780
source Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List
subjects Humans
Medicine
Medicine & Public Health
Neurosurgery
Pituitary Neoplasms - surgery
Quality of Life
Reproducibility of Results
Skull Base
title Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A26%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20the%20anterior%20skull%20base%20questionnaire%2035%20in%20endoscopic%20pituitary%20adenoma%20surgery&rft.jtitle=Neurosurgical%20review&rft.au=Castle-Kirszbaum,%20Mendel&rft.date=2022-12-08&rft.volume=46&rft.issue=1&rft.spage=7&rft.epage=7&rft.pages=7-7&rft.artnum=7&rft.issn=1437-2320&rft.eissn=1437-2320&rft_id=info:doi/10.1007/s10143-022-01921-1&rft_dat=%3Cproquest_cross%3E2753306780%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-726cec6408f32dcaf1eb13761082bfa9fd6a36efeeb44e696e5cf188d03e57353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2753306780&rft_id=info:pmid/36482220&rfr_iscdi=true